Comparative risk of serious infection among biologic therapies for inflammatory bowel disease in pediatric patients: A target trial emulation is a research paper published in Journal of Pediatric Gastroenterology and Nutrition (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
AbbVie Pharmaceuticals, Janssen Pharmaceuticals, The Hasso Serrano Foundation, Martin Schlaff, the Diane and Dorothy Brooks Foundation
National Institutes of Health, The Leona M. and Harry B. Charitable Trust, and the Chleck Family Foundation
National Institutes of Health, The Leona M. and Harry B. Charitable Trust, and the Chleck Family Foundation
AbbVie Pharmaceuticals, Janssen Pharmaceuticals, The Hasso Serrano Foundation, Martin Schlaff, the Diane and Dorothy Brooks Foundation
FWCI
0.98
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords